Jenburkt Pharmaceuticals Limited (BOM:524731)
India · Delayed Price · Currency is INR 1,074.50
+32.30 (3.10%)
At close: May 5, 2026
Jenburkt Pharmaceuticals Market Cap
Jenburkt Pharmaceuticals has a market cap or net worth of 5.08 billion as of May 6, 2026. Its market cap has increased by 5.36% in one year.
Market Cap
5.08B
Enterprise Value
4.57B
Revenue
1.79B
Ranking
n/a
PE Ratio
14.62
Stock Price
1,074.50
Market Cap Chart
Since November 21, 2001, Jenburkt Pharmaceuticals's market cap has increased from 33.01M to 5.08B, an increase of 15,287.04%. That is a compound annual growth rate of 22.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 5.08B | 5.61% |
| Dec 31, 2025 | 4.81B | -10.28% |
| Dec 31, 2024 | 5.36B | 78.59% |
| Dec 29, 2023 | 3.00B | 1.25% |
| Dec 30, 2022 | 2.96B | 21.19% |
| Dec 31, 2021 | 2.45B | 24.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anuh Pharma | 8.29B |
| Kopran | 7.83B |
| Sudarshan Pharma Industries | 7.28B |
| Kilitch Drugs (India) | 5.31B |
| ZIM Laboratories | 4.99B |
| Amanta Healthcare | 4.61B |
| Albert David | 4.32B |
| Medicamen Biotech | 3.72B |